Bicara Therapeutics Inc Common Stock
Price & Volume
Stats
See more52W Range | $7.80-$28.09 |
Market Cap | $638.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.66 |
News
See moreYahoo Finance • yesterday
Genmab reportedly nearing deal to acquire cancer drug developer Merus
Yahoo Finance • last month
Bicara Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance • last month
H.C. Wainwright lowers Bicara Therapeutics stock price target to $40 on expenses
Yahoo Finance • 2 months ago
Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
About
CEO | Dr. Claire Mazumdar Clemon M.B.A., Ph.D. |
Address | 116 Huntington Avenue, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
